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Abstract
Background: Academic infrastructures and networks for clinical research in primary care receive little funding in
Germany. We aimed to provide an overview of the quantity, topics, methods and findings of randomised controlled
trials published by German university departments of general practice.
Methods: We searched Scopus (last search done in April 2015), publication lists of institutes and references of
included articles. We included randomised trials published between January 2000 and December 2014 with a first
or last author affiliated with a German university department of general practice or family medicine. Risk of bias was
assessed with the Cochrane tool, and study findings were quantified using standardised mean differences (SMDs).
Results: Thirty-three trials met the inclusion criteria. Seventeen were cluster-randomised trials, with a majority
investigating interventions aimed at improving processes compared with usual care. Sample sizes varied between 6
and 606 clusters and 168 and 7807 participants. The most frequent methodological problem was risk of selection
bias due to recruitment of individuals after randomisation of clusters. Effects of interventions over usual care were
mostly small (SMD <0.3). Sixteen trials randomising individual participants addressed a variety of treatment and
educational interventions. Sample sizes varied between 20 and 1620 participants. The methodological quality of the
trials was highly variable. Again, effects of experimental interventions over controls were mostly small.
Conclusions: Despite limited funding, German university institutes of general practice or family medicine are
increasingly performing randomised trials. Cluster-randomised trials on practice improvement are a focus, but
problems with allocation concealment are frequent.
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Background
Practice-based randomised controlled trials (RCTs) in
primary care are essential, as they provide the basis for
evidence-based decision-making in a central sector of
health care [1]. Furthermore, being considered the gold
standard for clinical research, high-quality RCTs led by
general practitioners (GPs) are of crucial importance to
enhance the still limited acceptance of general practice/
family medicine as an academic discipline at German
universities [2]. In recent years, several countries, such
as the United Kingdom, the United States and the
Netherlands, have invested greatly in the establishment
of an efficient primary care research infrastructure
(university departments of general practice or family
medicine and practice networks) and the in practice-based
RCTs [3–5].
Although Germany is Europe’s most populous country,
its output of primary care research medicine lags far be-
hind that of the United Kingdom and the Netherlands
[3]. In 2000 only 5 of 36 German medical schools had a
chair of general practice or family medicine, and by 2006
family medicine institutes or divisions had been estab-
lished at 13 German universities [6]. By summer 2015,
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chairs had been established at 25 of 37 medical schools.
Recently, a group of researchers from German academic
departments of general practice published an analysis of
obstacles in clinical trials [5]. In Germany, laboratory re-
search is regarded more highly than clinical research.
The single national funding programme for clinical re-
search is highly competitive and specialist-dominated,
and it usually favours innovation rather than comparative
effectiveness research. General practice as an academic
discipline is still not fully implemented, and most of
the existing institutes are small. German GPs work in a
market-oriented competitive system, mostly in small
practices with a high caseload. Sustained funding for
research-oriented practice networks is almost inexistent
[5]. Despite these difficult circumstances, researchers in
German university departments of general practice or
family medicine have performed a number of randomised
trials in recent years. Our aim in this article is to provide a
descriptive overview of the current status of research
productivity by performing a systematic review of the
amount, topics, methods, quality and findings of rando-
mised trials carried out by German university departments
of general practice.
Methods
The aims and basic methods we used to search the lit-
erature, establish the selection criteria and process,
extract data, and assess risk of bias were predefined in
an unpublished protocol (in German).
Literature search
Publications were identified (1) by searching the Scopus
database (http://info.scopus.com/; last searched 22 Apr
2015); (2) by screening publication lists of existing de-
partments, institutes and divisions of general practice
or family medicine at German medical schools; and (3)
by tracking potentially relevant references in already-
included articles. We selected Scopus as a database for
electronic searching as it comprises PubMed/MEDLINE
and also covers European journals in languages other than
English, which are rarely listed in PubMed/MEDLINE. The
following algorithm was used for our Scopus database
search: AFFILCOUNTRY (deutschland) OR AFFILCOUN-
TRY (germany) AND AFFILORG (allgemeinmedizin) OR
AFFILORG (general practice) AND PUBYEAR > 2009
AND PUBYEAR < 2015 AND (Random* OR Cluster). Pub-
lication lists were obtained directly from the departments,
institutes and division and/or from their websites. Articles
published until 2010 had been originally searched and iden-
tified for a previous review on any original research publica-
tion done by researchers at German academic family
medicine departments [7, 8]. Articles published between
2011 and 2014 were identified by updated searches. (The
year 2010 was also searched to detect trials potentially
added to Scopus after completion of the search for our pre-
vious work.)
Study selection
We included randomised (individual- or cluster-level)
controlled trials published between January 2000 and
December 2014 in which the first or last author of at
least one relevant publication (study protocol and/or a
publication reporting trial results) was affiliated with a
general practice or family medicine department, institute
or division of a German medical school. (For simplicity,
only the term department is used in the rest of this art-
icle.) Within the overall project, we also collected pub-
lished study protocols of RCTs for which results were
not yet available by the end of 2014, but these are not
included in the systematic review presented here. There
were no predefined further exclusion criteria.
One reviewer screened titles and (to the extent avail-
able) abstracts of all Scopus search hits and excluded all
clearly irrelevant publications. The full text was obtained
for all remaining articles. For our previous review project
[7], these were any articles potentially reporting original
data. All articles actually reporting original data were then
analysed for study topic and bibliographical and methodo-
logical characteristics. For our present analyses, only arti-
cles reporting on a prospective clinical trial with a control
group or a protocol of such a study were considered as
potentially relevant and checked as full texts. Titles and
abstracts identified by our updated searches (2010–2014)
were screened for randomised trials; publications clearly
not reporting or related to a randomised trial were ex-
cluded. The first author checked all full texts obtained for-
mally for compliance with our selection criteria. In cases
of uncertainties, the senior author also read and assessed
the articles.
Data extraction
One reviewer extracted the following information (apart
from reference information included in the Endnote file)
from all included studies: study question in participants,
intervention, control, outcome format; in case of a disease
focus, the condition was recorded according to coding in
the International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision, and the Inter-
national Classification of Primary Care, Second Edition
(http://www.who.int/classifications/icd/adaptations/icpc2/
en/); information on authors; type and number of partici-
pating practices; the number of patients included, analysed
and completing the studies, as well as information on
recruitment; funding; study design issues, including
duration, randomisation, blinding, sample size calculation
and analysis; relevant outcome measures; and definition of
a primary outcome measure.
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Assessment of risk of bias
Risk of bias was assessed using the risk of bias assessment
tool of the Cochrane Collaboration [9] with items on ran-
dom sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, and selective reporting.
Assessment was performed on the basis of the instructions
given in the Cochrane Handbook [9] with a ‘rule book’ fur-
ther standardising procedures, taking into account the great
clinical and methodological diversity of the trials included
in our review. Assessments were done by the first author.
About half of the assessments were checked again by the
senior author.
Summarising the results of included trials
To provide a crude overview of the results of the included
trials, we used both vote count methods and effect size
calculations. For the vote count, the first author cate-
gorised overall study findings as ‘positive’ (findings in the
intervention group consistently and statistically signifi-
cantly better than in the control group), ‘trend positive’
(significant differences in favour of the intervention group
only for some outcomes), ‘no difference’, ‘trend negative’
and ‘negative’ (as ‘trend positive’ and ‘positive’ but favour-
ing the control group). Two vote counts were done: one
based on what study authors reported and concluded and
one according to the reviewer’s perception.
In addition, we calculated effect size estimates for pre-
defined main outcome measures or, if a main outcome
measure was not clearly defined, for the outcome we
considered most relevant. Raw data in four formats (means,
standard deviations and sample sizes; mean differences,
samples sizes and p values or confidence intervals; events
and number of participants per group; odds ratios and
confidence intervals) were entered into a Comprehensive
Meta-Analysis 3.3 spreadsheet (http://www.meta-analysis.
com/index.php). This software allows conversion of differ-
ent types of raw data into standardised mean differences
(with 95 % confidence intervals). Positive values indicate
better outcomes in the intervention group. We considered
standardised mean differences ≤0.4 as small effects, be-
tween 0.41 and 0.7 as moderate effects and >0.7 as large
effects [10].
Results
In our literature searches, we identified a total of 2228
references published between January 2000 and December
2014 (Fig. 1). On the basis of our review of titles and ab-
stracts or the full-text check of articles which had already
been identified for our previous review [7], a total of 2005
references were excluded as clearly irrelevant. Altogether,
full texts of 223 publications were obtained. Of these, 128
were excluded because neither the first nor the last author
was associated with a GP department, the studies were
not randomised trials, or the authors reported additional
information related to a randomised trial included which
was not directly related to the main results (e.g., accom-
panying qualitative studies or cross-sectional analyses
of baseline data). We extracted basic information on 60
studies described in 95 publications. Twenty-seven
studies in 33 publication were excluded from the re-
view (see Additional file 1 for references and Additional
file 2 for study characteristics). For 17 trials, protocols
(17 publications) were published between 2008 and
2014, but results were not available at the end of 2014.
We decided post hoc to exclude a further 10 trials (16
2228 references identified by searches 
Full text of 223 references obtained 
Information extracted for 60 trials (95 publications) 
ded 
2005 clearly irrelevant
128 clearly not meeting
selection criteria 
27 trials (33 publications) not inclu
- 17 protocols only
- 10 trials excluded post-hoc (see text) 
33 trials (62 publications) included 
Fig. 1 Flowchart of the study process
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publications) from the analyses for the present article
because we considered them irrelevant to the primary
aim of our overview. These studies comprised four tri-
als, all comparing acupuncture with a sham acupunc-
ture control having a first author with an affiliation
with an institute of family medicine or general practice
at the time of the publication for which we had definite
information that the studies had actually been planned
and performed when the author had worked at other
departments; five which were short-term experimental
trials focussed on physiological measures (e.g., effects
of suggestion on pupil size) without any direct relation
to the practice of family medicine; and one trial with a
last author with an affiliation with a German institute
of general practice but in which the study was per-
formed exclusively in the United States.
Thirty-three trials (sixty-two publications) were included
in the final analysis (Tables 1 and 2; see Additional file 1
for references). The number of trials increased sharply
over time from 2 trials published between 2000 and 2004
to 10 trials published between 2005 and 2009 and 21 trials
published between 2010 and 2014. Fifteen trials were
funded by federal or regional ministries of education or
health, eight trials received funding from a variety of other
non-industry resources (e.g., foundations, social health in-
surance), two were industry-sponsored, and for eight the
source of funding was not reported. We categorised 17
studies as cluster-randomised trials (trials in which the
unit of randomisation and the level on which the outcome
was measured differed; e.g., randomisation of practices
and outcome measurement on the level of individual
patients) and 16 trials as ‘normal’ randomised trials
(randomisation of individuals with outcome measure-
ment in the same individuals).
Cluster-randomised trials
The 17 cluster-randomised trials had a total of 37 study
arms (14 two-armed and 3 three-armed trials; Table 2).
Units of randomisation were quality circles or continu-
ing medical education groups of several physicians in 3
studies, practices in 12 studies and individual physicians
in 2 studies. Outcomes were measured on the level of
individual patients in all but one study, in which the out-
come was measured on the level of physicians. The
number of randomised clusters varied between 6 and
303, and the number of included patients (physicians in
1 study) ranged between 168 and 7807. The conditions
or clinical problems and outcomes assessed varied widely;
no specific subject was investigated in more than one
study. The majority of interventions were focused on the
improvement of processes (managed care, more efficient
or evidence-based strategies, better communication), and
only a few were focused on defined, specific treatment
strategies (e.g., a weight reduction program or a fall
prevention intervention for the elderly). Control inter-
ventions were no intervention/usual care or minimal
interventions unlikely to have relevant effects.
Many cluster-randomised trials were logistically com-
plex and associated with high risk of bias (Table 3).
While the generation of the random sequence was either
adequate (ten studies) or not reported (seven studies),
we considered the risk of selection bias related to alloca-
tion concealment high in ten studies, unclear in a fur-
ther two and low in only five. The allocation of clusters
was mostly concealed adequately. However, in those ten
studies which received a high-risk rating, patients were
explicitly or probably recruited after the practices knew
their allocation status. Most authors seem to have been
aware of this problem but were unable to manage re-
cruitment otherwise. While in some trials this did not
result in obvious imbalances, in others the number of
patients recruited in the intervention and control groups
differed beyond chance or there were clinically relevant
differences in baseline characteristics of patients. Given
the nature of the interventions tested, blinding of prac-
tices and individuals was not possible in any trial. While
outcomes measured were partly objective, performance
bias on the level of co-interventions cannot be ruled out.
In five trials, a relevant proportion of randomised clusters
did not recruit any patients and/or had a high percentage
of incomplete outcome data, which resulted in a high risk
of attrition bias. We considered the risk of major bias on
the level of reporting outcomes to be low based on our
(liberal) operationalization of this item. In summary, each
of the cluster-randomised trials had a high risk of bias for
at least one item.
In the vote count, the conclusions of authors were
categorised as ‘positive’ for five trials, as ‘trend positive’
in three and as ‘no difference’ in nine trials. The vote
count based on the reviewer’s conclusion yielded similar
categorisations (four, three and ten trials, respectively).
Effect sizes estimates could be calculated for 15 trials
with 18 comparisons of an intervention with a control
group (Table 4). Only two trials had moderately large
group differences, with standardised mean differences
of −0.60 and −0.63, respectively. In all other trials, dif-
ferences were small, ranging from −0.30 to 0.17. Confi-
dence intervals did not include zero in eight trials.
‘Normal’ randomised trials
In a total of 16 trials with 33 study arms (one 3-armed
trial), the unit of randomisation and the level of outcome
measurement were the same (Table 2). In 11 trials, re-
searchers investigated the effectiveness of specific clin-
ical interventions; these interventions were allocated to
individual patients. Conditions as well as experimental
and control interventions investigated were highly vari-
able. Six of the eleven trials investigated complementary
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Table 1 Characteristics of included studies - cluster-randomised trials (n = 17)
First author, year Participants’ conditions Interventions Controls Main outcomes Unit random. Sample sizea
Altiner, 2007 Cough Educational intervention (GPs and patients) No intervention Antibiotic prescribing Physician 104/2787
Becker, 2010 Low back pain Group 1: Multifaceted guideline intervention Postal dissemination
of the guideline
Functional capacity Practice 118/1378
Group 2: 1 + training of practice nurses
Erler, 2012 Elderly with chronic kidney disease Multifaceted intervention helping
adequate drug dosing
Usual care Prescription exceeding
recommended doses >30 %
Practice 46/404
Freiberger, 2013 Community-dwelling elderly Risk of falls prevention program No intervention Risk of falling (main outcome falls
not yet available)
Practice 33/378
Gensichen, 2009 Depression Case management (communication,
monitoring, behavioural activation)
Usual care Depressive symptoms Practice 74/626
Junius-Walker, 2012 Elderly GP patients Training on structured priority-setting
consultation
No training Doctor-patient agreement
on priorities
Practice 42/347
Kaufmann-Kolle, 2011 Asthma bronchiale Quality circles with open benchmark Traditional anonymous




Krones, 2008 All undergoing cholesterol
measurement
Communication/shared decision-making
in cardiovascular risk patients
Training on other subjects Patient satisfaction, risk scores,
participation
CME groups 14/1132
Mehring, 2013 Individuals with BMI ≥25 kg/m2 Web-based weight reduction program Usual care Weight reduction at 12 weeks Practice 92/186
Mehring, 2014 Individuals willing to stop smoking Web-based weight reduction program Usual care Biochemically confirmed
smoking status at 12 weeks
Practice 92/168
Peters-Klimm, 2009 Chronic heart failure Multifaceted, interdisciplinary medical
educational intervention
Single 3-h lecture Quality of life Practice 37/168
Rosemann, 2007 Osteoarthritis Group 1: Case management training GPs No intervention Quality of life (Arthritis Impact
Measurement Scales Short Form)
Physician 75/1125
Group 2: 1 + courses also for nurses
Szecsenyi, 2012 Type 2 diabetes Ideally implemented disease management Usual disease management
care
Achievement of target values
for HbA1c and blood pressure
Practice 177/7807
Tinsel, 2013 Hypertension Shared decision-making training No training (usual care) Patients’ perceived participation,
blood pressure
Practice 37/1120
Vollmar, 2007 Dementia Training in evidence-based dementia
treatment (two slightly different groups)
Basic information
(usual care)
Time to nursing home placement,
death
Practice 303/390




Knowledge gain Quality circle 26/305
Vormfelde, 2014 Patients receiving oral
anticoagulation therapy
Educational program for patients
provided by practice nurses
Brochure only Knowledge, feelings about safety,
complications
Practice 22/345
Unit random. unit of randomisation, GP general practitioner, CME continuing medical education, HbA1c haemoglobin A1c, BMI body mass index
See Additional file 1 for references











Table 2 Characteristics of included studies: ‘normal’ randomised trials (n = 16)




Randomised trials investigating specific treatments (n = 11)
Bleidorn, 2010 Uncomplicated urinary
tract infection
Ibuprofen Ciprofloxacin Symptom resolution at day 4 Patient 80




Non-specific information Functional capacity (Hannover
Functional Ability Questionnaire)
Patient 189
du Moulin, 2009 COPD Home-based exercise training No intervention 6-minute walk test, quality of life,
lung function
Patient 20
Frese, 2012 GP patients older than
70 years of age
Comprehensive geriatric assessment Usual care Mortality, nursing home admission Patient 1620
Gastpar, 2003 Neurotic anxiety Kava special extract WS 1490 Placebo Anxiety Status Inventory Patient 141
Hensler, 2009 Common cold Intramuscular autologous blood
therapy
Placebo Duration of cold Patient 139







Sick days Patient 80
Klein, 2013 Non-specific neck pain Strain-counterstrain (osteopathic
technique)
Sham intervention Range of motion and pain intensity Patient 61
Peters-Klimm, 2010 Chronic heart failure Case management (telephone
monitoring and home visits)
Usual care Quality of life, Kansas City
Cardiomyopathy Questionnaire
Patient 199
Schencking, 2013 Osteoarthritis (hip
or knee)
Group 1: Kneipp hydrotherapy Both Pain intensity, quality of life, mobility Patient 30
Group 2: Conventional physiotherapy
Voigt, 2011 Migraine Osteopathic manipulative treatment No intervention Migraine Disability Assessment
(MIDAS), quality of life, pain
Patient 42
Randomised trials on other topics (n = 5)
Bergold, 2013 First-year residents Online course in evidence-based
medicine
Wait list Knowledge gain First-year
resident
120
Blank, 2013 Medical students Additional near-peer teaching for
physical examination





Butzlaff, 2004 General practitioners Access to computerized guidelines No specific access Knowledge gain Physician 72
Hoffmann, 2014 Physicians and nurses of
GP practices
Team-based patient safety culture
assessment and intervention
Short, facultative seminar on error
management
Error management Practice 65
Müller-Bühl, 2011 Adult GP patients Answering three questions before completing
the SF-36 quality of life questionnaire
Completing the SF-36 as usual Number of missing items Patient 215
COPD chronic obstructive pulmonary disease, GP general practitioner, SF-36 36-item Short Form Health Survey, Unit random. unit of randomisation











or alternative treatments (e.g., herbal drugs, autologous
blood therapy, osteopathy or hydrotherapy). Sample sizes
varied between 20 and 1620 patients. In the five remaining
trials, researchers investigated educational interventions
(three trials), the impact of access to computerized guide-
lines (one trial) and a methodological issue relevant to
quality of life measurement in heterogeneous GP patient
populations (one trial). The unit of randomisation
was variable. Sample sizes varied between 72 and 215
participants.
In general, ‘normal’ randomised trials were logistically
and methodologically less challenging than cluster-
randomised trials. While not all trials reported details on
sequence generation and allocation concealment, the
Table 3 Risk of bias













Altiner, 2007 Low High High Low High Low
Becker, 2010 Low High High High High Low
Erler, 2012 Low Low High Low Low Low
Freiberger, 2013 Low High High High Unclear Low
Gensichen, 2009 Low High High High Low Low
Junius-Walker, 2012 Unclear High High High Unclear Low
Kaufmann-Kolle, 2011 Unclear High High Unclear High Low
Krones, 2008 Unclear High High High Unclear Low
Peters-Klimm, 2009 Low Low High Low Unclear Low
Mehring, 2013 Low High High Low Unclear Low
Mehring, 2014 Low High High Low Unclear Low
Rosemann, 2007 Unclear Low High High Unclear Low
Szecsenyi, 2012 Unclear Unclear High Low Low Low
Tinsel, 2013 Low Low Unclear Unclear High Low
Vollmar, 2007 Unclear High High Low Low Low
Vollmar, 2010 Unclear Low High Unclear High Low
Vormfelde, 2014 Low Unclear High High Unclear Low
Randomised trials investigating specific treatments
Bleidorn, 2010 Low Low Low Low Low Low
Bücker, 2010 Low Low High High High Low
du Moulin, 2009 Low Low High Low Unclear Low
Frese, 2012 Unclear Unclear Low Low High Low
Gastpar, 2003 Low Low Low Low Low Unclear
Hensler, 2009 Unclear Low Low Low Unclear Low
Jobst, 2005 Low Low High High Unclear Low
Klein, 2013 Low Low High Low Low Low
Peters-Klimm, 2010 Low Low High High Unclear High
Schencking, 2013 Low Low High High Low Unclear
Voigt, 2011 Unclear Unclear High High Low High
Randomised trials on other topics
Bergold, 2013 Low Low High High Low Low
Blank, 2013 Low Low High Low High Low
Butzlaff, 2004 Low Unclear High High Low Low
Hoffmann, 2014 Unclear Unclear High Low Low Low
Müller-Bühl, 2011 Unclear Unclear Unclear Unclear Low Low
See Additional file 1 for references
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risk of bias was never considered high. Instead, the risk
of performance and measurement bias was considered
high in the majority of studies due to the lack of blind-
ing and/or use of subjective outcomes. Risk of bias due
to incomplete outcome data was highly variable due to
differences in challenges (some short-term studies did
not have any attrition and had no or little missing data)
and reporting or handling of the problems experienced.
In two trials, there was clear evidence of biased reporting,
either by selecting outcomes or by reporting inadequate
Table 4 Effect size estimates
First author, year Outcome used for effect size estimation SMD LL UL
Cluster-randomised trials
Altiner, 2007 Frequency of antibiotic prescription 0.30 0.14 0.46
Becker, 2010 Functional capacity 6 (group 1 vs. controls) 0.15 0.01 0.29
Becker, 2010 Functional capacity 6 (group 2 vs. controls) 0.11 −0.03 0.25
Erler, 2012 Number of patients with inadequate prescriptions 0.23 −0.11 0.56
Gensichen, 2009 Depression scores 0.22 0.05 0.38
Krones, 2008 Patient participation and satisfaction score 0.23 0.10 0.35
Peters-Klimm, 2009 Quality of life physical function −0.17 −0.50 0.16
Rosemann, 2007 Arthritis impact, lower body (group 1 vs. controls) 0.08 −0.09 0.25
Rosemann, 2007 Arthritis impact, lower body (group 2 vs. controls) 0.17 0.00 0.34
Szecsenyi, 2012 Number of patients reaching treatment targets 0.01 −0.04 0.07
Tinsel, 2013 Shared decision-making score 0.07 −0.06 0.20
Vollmar, 2007 Institutionalisation (group 1 vs. controls) 0.08 −0.24 0.41
Vollmar, 2007 Institutionalisation (group 2 vs. controls) −0.07 −0.38 0.25
Vormfelde, 2014 Knowledge scores anticoagulant treatment 0.63 0.41 0.85
Freiberger, 2013 Mobility 0.27 0.05 0.49
Mehring, 2013 Weight reduction 0.60 0.27 0.92
Mehring, 2014 Smoking cessation 0.08 −0.61 0.77
Vollmar, 2010 Knowledge gain 0.02 −0.28 0.33
Randomised trials investigating specific treatments
Bücker, 2010 Functional capacity 0.28 −0.10 0.66
Peters-Klimm, 2010 Quality of life physical functioning −0.04 −0.38 0.31
Bleidorn, 2010a No symptom resolution 0.15 −0.37 0.68
du Moulin, 2009 6-minute walk test 1.03 0.10 1.97
Frese, 2012 Death 0.14 0.05 0.22
Gastpar, 2003 Anxiety scores 0.15 −0.18 0.48
Hensler, 2009 Illness duration 0.05 −0.32 0.41
Jobst, 2005a Illness days 0.02 −0.42 0.46
Klein, 2013 Mobility restriction, neck 0.24 −0.27 0.74
Schencking, 2013 Pain (group 1 vs. controls) 0.20 −0.68 1.08
Schencking, 2013 Pain (group 2 vs. controls) 0.10 −0.78 0.97
Randomised trials on other topics
Bergold, 2013 Knowledge of EBM 0.76 0.38 1.14
Blank, 2013 Score for clinical examination quality 1.16 0.58 1.74
Butzlaff, 2004 Knowledge gain 0.11 −0.43 0.65
Hoffmann, 2014 Error management −0.06 −0.57 0.45
Müller-Bühl, 2011 Number of missing items 0.25 −0.02 0.52
SMD standardised mean difference, LL lower limit of the 95 % confidence interval, UL upper limit of the 95 % confidence interval
aStudies comparing two active treatments (equivalence or non-inferiority trials)
Data are presented as standardised mean differences with 95 % confidence intervals. Negative values indicate better outcomes in the intervention group.
See Additional file 1 for references
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analyses (focus on changes and inference testing within
groups).
The authors’ conclusions were ‘positive’ in four trials,
‘trend positive’ in six and ‘no difference’ in six trials (re-
viewer’s conclusion three trials ‘positive’, five trials ‘trend
positive’ and eight trials ‘no difference’). Standardised
mean differences could be calculated for 15 trials includ-
ing 16 comparisons (Table 4, lower part). Two trials
actually compared active treatments. Large differences
were reported in two trials and moderately large differ-
ences in one trial. In all other trials, point estimates of
standardised mean differences were <0.3.
Discussion
Despite limited funding, German university institutes for
general practice or family medicine increasingly perform
randomised trials; yet, the total number of 33 trials rele-
vant to primary care published in a period of 15 years
seems modest. In cluster-randomised trials, we noticed
an emphasis on interventions aimed at improving pro-
cesses in practices, while trials on drugs were very rare.
The methodological quality of the trials was variable,
with frequent relevant problems related to allocation
concealment in cluster-randomised trials. Effects of the
tested interventions over usual care or minimal inter-
ventions were mostly small.
It is somewhat difficult to compare the RCT output of
university departments for general practice in Germany
with that of other countries, as there is very limited in-
formation on such output internationally. The only sys-
tematic analysis limited to ‘RCTs with a general practice
setting’ we found in the literature was published by
Kortekaas et al. in 2012 [2]. These authors searched
MEDLINE using the text words and/or MeSH (‘medical
subject headings’) terms ‘general practice’, ‘primary
healthcare’ or ‘family medicine’ to identify relevant trials
published between 1990 and 2010. The 1935 publications
on RCTs included 549 originated from the United States,
511 from the United Kingdom, 201 from Scandinavia, 194
from the Netherlands and 480 from a variety of other
countries. The number of trials originating from Germany
was not reported in the published review, but the first
author kindly provided us an unpublished list of the 52
German studies. Of the 38 publications included by
Kortekaas et al. that were published between 2000 and
2010, 8 were also included by us (while we identified
additional 9 trials for this period), 3 were relevant
protocol publications without results (also identified by
us but excluded from the analysis presented), 1 was an
additional publication on a trial already included in
both reviews, 1 turned out not to be a randomised trial
and 1 publication was a duplicate. The remaining 24
publications were not included by us because in 22 not
a single author was affiliated with a GP department (or
at least reported a private general practice as contact)
and in 2 only a middle author had a GP department af-
filiation. This comparison shows that, depending on the
objective and the methods used, bibliometric analyses
can produce quite different findings. Yet, it makes clear
that, compared with countries leading in primary care re-
search (UK, USA, Netherlands, Scandinavian countries),
Germany’s output of RCTs in the area of academic family
medicine is rather low, and that many ‘primary care trials’
in Germany are conducted with or on GPs rather than by
GPs.
There is a remarkable focus by German GP institutes
on process-oriented cluster-randomised trials. Also, among
the 16 protocols of trials without published results by 2014
identified by our search, 12 described cluster-randomised
trials (see Additional file 2). This focus seems well
compatible with the priorities in the research agenda of
the European General Practice Research Network that
ask for RCTs ‘which take into account broad issues
such as patient preferences, multimorbidity, quality of
life and social and environmental circumstances’ ([11]
p. 11). Also, when we screened systematic reviews with
the term primary care in the title in the Cochrane library
(http://www.cochranelibrary.com/), it became clear that
primary care research is focused more on complex and
process interventions than on single specific interventions
such as a defined drug. The methodological problems with
allocation concealment and attrition observed in com-
pleted German cluster-randomised trials fit very well with
the problems described in analyses of such trials in general
[12–15]. It seems to us that the protocols of the partly
very large newly planned or ongoing trials try to take these
problems and former experiences into account. We are
not aware of any systematic analyses of effect sizes in gen-
eral practice trials across conditions, but it seems plausible
to us that, in the primary care setting with its multiple in-
fluence factors, intervention effects are often small. Yet,
for some of the interventions tested in the trials reviewed
by us, we wondered whether these were conceptually
really promising and/or well implemented.
When interpreting our findings, it must be kept in
mind that we searched and included only trials in which
the first or last authors were affiliated with a German
university GP department. Therefore, our results cannot
be adopted for RCTs authored by GPs without such an
affiliation. However, our check of the additional publica-
tions identified by Kortekaas et al. [2] suggests the num-
ber of such studies is small. We excluded ten trials post
hoc as they either were conducted when authors were
working at other departments (and only written up later)
or had no thematic relation to primary care whatsoever.
We think these exclusions were necessary to allow for a
judgement of the real RCT output of German academic
GP departments relevant for their field. Due to limited
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resources, many working steps in this review were per-
formed by a single author, with only some checks done
by a second author. Therefore, some extraction or assess-
ment errors might have gone undetected. The standardised
mean differences calculated by us should be interpreted
only as crude indicators of how large differences between
groups were and should not be used for clinical decision-
making.
Conclusions
Researchers in Germany’s academic departments of general
practice and family medicine increasingly perform and
publish RCTs. However, without increased and sustained
funding for research infrastructure and single trial pro-
jects, there will be little chance to catch up with leading
countries such as the United Kingdom, the Netherlands,
Scandinavian countries or the United States. We hope that
our analysis will help to avoid some preventable short-
comings in future trials.
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